Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on May 5, 2005

Stroke. 2005
Published online before print May 5, 2005, doi: 10.1161/01.STR.0000165931.77045.ee
A more recent version of this article appeared on June 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/6/1341    most recent
01.STR.0000165931.77045.eev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krams, M.
Right arrow Articles by Berry, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krams, M.
Right arrow Articles by Berry, D. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Clinical Trials
*Stroke
Related Collections
Right arrow Emergency treatment of Stroke
Right arrow Other Stroke Treatment - Medical

Submitted on November 5, 2004
Revised on January 26, 2005
Accepted on January 28, 2005

The Past Is the Future. Innovative Designs in Acute Stroke Therapy Trials

Michael Krams MD; Kennedy R. Lees MD; and Donald A. Berry PhD*

From Pfizer Global Research and Development (M.K.), Groton, Conn; the University Department of Medicine and Therapeutics (K.R.L.), Gardiner Institute, Western Infirmary, Glasgow, UK; and the Department of Biostatistics (D.A.B.), M. D. Anderson, Houston, Tex.

* To whom correspondence should be addressed. E-mail: dberry{at}mdanderson.org.


Key words: models, theoretical • neuroprotection




This article has been cited by other articles:


Home page
StrokeHome page
G. Howard
Nonconventional Clinical Trial Designs: Approaches to Provide More Precise Estimates of Treatment Effects With a Smaller Sample Size, but at a Cost
Stroke, February 1, 2007; 38(2): 804 - 808.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
B. H. Dobkin
Rehabilitation and Functional Neuroimaging Dose-Response Trajectories for Clinical Trials
Neurorehabil Neural Repair, December 1, 2005; 19(4): 276 - 282.
[Abstract] [PDF]